Nom du produit:4-chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine
IUPAC Name:4-{4-chloropyrrolo[2,1-f][1,2,4]triazin-6-yl}-1-methyl-1H-pyrazole
- CAS：1703794-33-5
- Formule moléculaire：C10H8ClN5
- Pureté：95%+
- Numéro de catalogue：CM329513
- Poids moléculaire：233.66
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1703794-33-5
- Formule moléculaire:C10H8ClN5
- Point de fusion:-
- Code SMILES:CN1N=CC(C2=CN3N=CN=C(Cl)C3=C2)=C1
- Densité:
- Numéro de catalogue:CM329513
- Poids moléculaire:233.66
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Pyrroles
- Pyrrole is a five membered heterocyclic compound with the molecular formula of C4H5N. Pyrrole has a ring composed of four carbon atoms and one nitrogen atom. Pyrrole is easy to polymerize in the air. Pyrrole is the parent compound of many important biological substances (such as bile pigment, porphyrin and chlorophyll). Pyrrole scaffolds are widely used in biological and pharmaceutical fields. Pyrrole is a special heterocyclic scaffold, which exists in many natural products, drug molecules and pesticides, and has shown its application in materials science.
- Pyrrole,Where to Buy Pyrroles-Chemenu
- Pyrrole,Where to Buy Pyrroles
- Pyrrole is a heterocyclic, aromatic, organic compound, a five-membered ring with the formula C 4H 4NH. It is a colorless volatile liquid that darkens readily upon exposure to air. Substituted derivatives are also called pyrroles, e.g., N-methylpyrrole.
- Pyrazoles
- Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
- Pyrazone
- Custom pyrazone for customers from all over the world are our main business.
Column Infos
- Avapritinib
- Blueprint Medicines announced the European Commission has approved AYVAKYT® (avapritinib) for the treatment of adult patients with indolent systemic mastocytosis (ISM) with moderate to severe symptoms inadequately controlled on symptomatic treatment. AYVAKYT is the first and only approved therapy for people living with ISM in Europe. AYVAKYT was designed to potently and selectively target KIT D816V, the primary underlying driver of the disease.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
